IPN10200
Sponsors
Ipsen Innovation
Conditions
Cervical DystoniaEpisodic Migraine
Chronic MigraineTreatment of Moderate to Severe Upper Facial Lines
Phase 1
Phase 2
A Phase II, Multicentre, Randomised, Double-blind, Parallel-Group, Placebo controlled Study to Evaluate the Efficacy and Safety of IPN10200 as a Treatment for Cervical Dystonia in Adult Participants
RecruitingCTIS2024-519248-34-00
Start: 2025-06-17Target: 91Updated: 2025-11-17
A multicentre, randomised, double-blind, placebo-controlled, dose escalation and dose finding phase II study to evaluate the safety and efficacy of IPN10200 in the prevention of episodic or chronic migraine in adults
Not yet recruitingCTIS2024-511101-28-00
Target: 311Updated: 2025-09-17